MindMed Just Dosed Their First Patient in LSD Clinical Trial for Anxiety
We're one step closer. Mindmed just dosed their first patient in their clinical trial using LSD to treat anxiety.
Read More
We're one step closer. Mindmed just dosed their first patient in their clinical trial using LSD to treat anxiety.
Read More
Super famous anti-aging biohacker Bryan Johnson shared an intriguing experiment with ketamine and brain activity.
Read More
An analysis in Psychology Today suggests patients may find using psychedelics for pain may offer significant benefits.
Read More
PharmaTher has secured FDA approval for its ketamine product KETARx, which is specifically for surgical pain management.
Read More
Twenty four Arizonans living with post traumatic stress disorder will participate in a groundbreaking study next month.
Read More
The compounded GLP-1 market has become fiercely competitive. Most clinics compete on price and speed. Mindful Labs wants to change
Read More
Psychedelic retreats have moved from the fringes of wellness culture into the full blown mainstream travel market.
Read More
Psilocybin is moving into the mainstream faster than science and policy can keep up. Will this interest in move the
Read More
The FDA's decision could deliver the first psychedelic medicine approved by the FDA as soon as this summer.
Read More
Aaron Rodgers' ayahuasca experience is big for the sports world. It also opens up important conversations about psychedelic edeucation.
Read More